Detalhe da pesquisa
1.
Effect of Empagliflozin with or without the Addition of Evolocumab on HDL Subspecies in Individuals with Type 2 Diabetes Mellitus: A Post Hoc Analysis of the EXCEED-BHS3 Trial.
Int J Mol Sci
; 25(7)2024 Apr 08.
Artigo
Inglês
| MEDLINE | ID: mdl-38612917